Scientists at CSIRO, Australia's national science agency, have identified simpler and less invasive methods to improve ...
The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for CTx-1301 for the treatment of attention deficit/hyperactivity disorder (ADHD) in children and adults.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback